Flynn James E 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-17 11:01 am Purchase |
2021-03-15 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 12,435,751 9.880% |
6,553,398 (+111.41%) |
Filing |
| 2021-02-12 12:31 pm Purchase |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 5,882,353 4.985% |
3,299,062 (+127.71%) |
Filing |